Navigation Links
In Search Of Drugs From the Ocean

Researchers say most of the existing drugs on the market are losing their effectiveness, since most of them are derived from soil bacteria hence researchers feel that the ocean is a new place to look for miracle drugs.//

More than 1 million microorganisms fill every milliliter of seawater. Each one could lead to a life-saving treatment for some of our deadliest diseases. Many marine organisms are already in development to benefit humans. Bryozoans, gastropods and sponges work against cancer. Marine fungus is an anti-inflammatory, and sea whips fight tuberculosis. Currently, there are about 30 marine-derived pharmaceuticals in various stages of clinical trials.

Researchers say they are uncovering new microorganisms on a weekly basis and they feel that there is some relevant medical application of some of these microorganisms. In conclusion researchers say they can look forward to the day when the microorganisms lurking the sea could improve human health worldwide.
'"/>




Page: 1

Related medicine news :

1. In Search Of A New Drug To Target Cholesterol
2. In Search Of A New Drug To Target Cholesterol
3. Search For Bigfoot Creature To Be Delayed
4. Australia In Search Of A Better Way to Handle Critically Ill Patients and Balance Elective Surgery
5. Intensive Search On For Nurse Killer
6. Search for an Effective and Safe Hepatitis C Vaccine
7. A Futile Search for Cancer Gene
8. Search for Human Pheromone
9. Internet Searches Fail To Give Useful Information To Cancer Patients
10. Weight Loss and Intimacy -- A Search for Self
11. ‘Search and Destroy’ operation against dengue mosquitoes in Philippins

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Search Drugs From the Ocean

(Date:11/29/2009)...g mannequins to teach doctors-in-training how to d... to improve their skills without compromising pati... Henry Ford Hospital. , The study shows that thi...le tool to improve medical residents, knowledge, d... more common ultrasound-guided procedures, includi...
(Date:11/29/2009)...GTON, Minn., Nov. 29 Acuo Technolo... management software, data migration tools and ser...ed AcuoShare that allows image sharing across the ..., The AcuoShare solution is based on the versat...ware. The Acuo AcuoShare enables secure access fr...
(Date:11/29/2009)...$1,300 round of treatment equals a $41,000 pay rai...8 (HealthDay News) -- Psychological therapy may be...etting a raise or winning a lottery prize, suggest... on thousands of people who provided information a...crease in happiness from a $1,329 course of therap...
(Date:11/29/2009)... "The YogaForce A-Line Athletic Mat is...ndrew Weil, M.D., author and physician best known ...egrative medicine. Go to www.yogaforce.com and ...the gift list. , San Fran...e for the holidays, the YogaForce newly patented, ...
(Date:11/28/2009)...AGO, Nov. 28 Welcome to syngo&...or the clinical routine from Siemens Healthcare....ions System (PACS) from Siemens where 2D, 3D, an... .plaza is poised to change the way multimodality...innovation at the 95th Scientific Assembly and A...
Breaking Medicine News(10 mins):Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3
...rt: 2009 Annual Meeting of Shareholders , , MCKI...: TMK ) announces the following Webcast: , , , ... When: April 30th, 2009 @ 11:00 a.m. EDT, ...ess above., Contact: Davida Walls of TORCHMARK...
...Maine, April 24 IDEXX Laboratories, Inc. (Nasdaq:...rst quarter of 2009 were $236.5 million compared t...e decrease in revenues was due primarily to the un...e divestiture in the fourth quarter of 2008 of our...
... Results of a recent two-year study s...ents living with Pulmonary Arterial Hypertension (...hich the small blood vessels in the lungs become s... Paris, FR (PRWEB) April 24, 2009 ...
... Minneapolis-based ad agency, Preston...aise awareness of the National Marrow Donor Progra...B) April 24, 2009 -- The National Marrow Donor Pro... awareness of the importance of joining the Be The...
... The Khanna institute of Lasik gives ...ision care and restoration. , ...- Oaks Christian is an affluent, prestigious, priv...erica,s youth, by donating several surgeries, educ...
...ia Day Events Held in Nairobi , London ,... April 23 To honor the theme for World Malaria Da...ndsen is stepping up production of its best sellin...n one million lives every year, and leaves half of...
Other Medicine News:Health News:IDEXX Laboratories Announces First Quarter Results 2Health News:IDEXX Laboratories Announces First Quarter Results 3Health News:IDEXX Laboratories Announces First Quarter Results 4Health News:IDEXX Laboratories Announces First Quarter Results 5Health News:IDEXX Laboratories Announces First Quarter Results 6Health News:IDEXX Laboratories Announces First Quarter Results 7Health News:IDEXX Laboratories Announces First Quarter Results 8Health News:IDEXX Laboratories Announces First Quarter Results 9Health News:IDEXX Laboratories Announces First Quarter Results 10Health News:IDEXX Laboratories Announces First Quarter Results 11Health News:IDEXX Laboratories Announces First Quarter Results 12Health News:IDEXX Laboratories Announces First Quarter Results 13Health News:IDEXX Laboratories Announces First Quarter Results 14Health News:IDEXX Laboratories Announces First Quarter Results 15Health News:IDEXX Laboratories Announces First Quarter Results 16Health News:IDEXX Laboratories Announces First Quarter Results 17Health News:IDEXX Laboratories Announces First Quarter Results 18Health News:New Study Shows Long-Term Benefits for Patients with Pulmonary Arterial Hypertension 2Health News:New Study Shows Long-Term Benefits for Patients with Pulmonary Arterial Hypertension 3Health News:Be The MatchSM Brand Campaign Launches 2Health News:Be The MatchSM Brand Campaign Launches 3Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 3
(Date:11/28/2009)... Siemens Healthcare redefines prod...(Total imaging matrix) technology and with its new...technologies are introduced in the new MAGNETOM &#...ra* 3T scanners at the 95th Scientific Assembly an...rth America (RSNA) from November 29 to December 3 ...
(Date:11/26/2009)...outh Africa, Nov. 26 The 2009 Fros...Award in the Generic Pharmaceutical Market is pres...(Logo: http://www.newscom.com/cgi-bin/prnh/200811...d, the following criteria were used to benchmark C... growth strategy and implementation, degree of inn...
(Date:11/25/2009)...ov. 25 Pharmasset, Inc. ...company committed to discovering, developing and c...ns, reported financial results for the fiscal year...harmasset held $58.4 million in cash, cash equival...Update and 2009 Highlights ,, RG7128 ,, ...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Synthetech Announces Fiscal 2009 Results 47845 1Synthetech Announces Fiscal 2009 Results 47845 2Synthetech Announces Fiscal 2009 Results 47845 3Synthetech Announces Fiscal 2009 Results 47845 4Synthetech Announces Fiscal 2009 Results 47845 5Synthetech Announces Fiscal 2009 Results 47845 6Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 1Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 2Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 3Americas Future Now Straw Poll 3A Progressives See Health Care Reform With Public Option As Top Priority 47838 1Americas Future Now Straw Poll 3A Progressives See Health Care Reform With Public Option As Top Priority 47838 2
...s Phase 3 Plans with FDA, PRINCETON, N.J., Sept. ...t successfully completed two key clinical trials i... low-dose, once-weekly,contraceptive patch, which ... AG-200-15. The Phase 2b safety and efficacy study...n suppression, cycle control and safety. The,pharm...
...Sept. 3 A sub-analysis of,the TRITON-TIMI 38 clin...mpared with clopidogrel significantly reduced the ...t vs. 9.7 percent, p<0.0001), regardless,of wh...tery-opening,procedure known as percutaneous coron...neously during the longer-term maintenance phase. ...
Other Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6
HDL Cholesterol (PEG)
Cholesterol/HDL
HDL-Cholesterol Direct Reagent
HDL Cholesterol
Medicine Products: